Medical/Pharmaceuticals
CStone successfully hosted the first U.S. R&D Day in New York
* Among CStone's 15 cancer drug candidates, five candidates are in pivotal late-stage clinical development, with a total of 13 on-going registrational trials. * The Company has implemented its pipeline strategy for early-stage candidates and combination therapy. With an established clinical d...
2020-01-24 08:03
537
Saluda Medical Highlights Multiple Presentations Featuring Evoke® ECAP-Controlled, Closed-Loop SCS System at NANS Annual Meeting
Includes 8 Oral Presentations and Award of Best Clinical Abstract ARTARMON, Australia, Jan. 21, 2020 /PRNewswire/ -- Saluda Medical Pty Limited ("Saluda Medical") today announced that data from multiple studies evaluating the company's Evoke® ECAP-Controlled, Closed-Loop Spinal Cord Stimulation (...
2020-01-21 20:00
366
Transcenta Announces Acceptance by NMPA of IND Application of a Novel Humanized Claudin 18.2 Monoclonal Antibody
SUZHOU and HANGZHOU, China, Jan. 20, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D and manufacturing of antibody-based therapeutics, announces today that an investigational new drug (IND) appl...
2020-01-21 00:00
384
TenNor Therapeutics Received FDA Orphan Drug Designation
SUZHOU, China, Jan. 20, 2020 /PRNewswire/ -- TenNor Therapeutics, a clinical-stage, global biopharmaceutical company has received FDA Orphan Drug Designation for TNP-2092 to treat prosthetic joint infections. Medical devices such as prosthetic joints, central venous catheters and artificial hear...
2020-01-20 20:50
351
Bridge Biotherapeutics Announces FDA IND Clearance for BBT-176, an EGFR TKI for NSCLC
SEONGNAM, South Korea, Jan. 19, 2020 /PRNewswire/ -- Bridge Biotherapeutics Inc., a clinical stage biotech company headquartered in Seongnam, Republic of Korea, announced that the Investigational New Drug (IND) application submitted to the U.S. Food and Drug Administration (FDA) has been cleared ...
2020-01-20 10:44
286
111, Inc. Featured at 38th Annual JP Morgan Healthcare Conference
SHANGHAI, Jan. 17, 2020 /PRNewswire/ -- Junling Liu, co-founder, Chairman, and Chief Executive Officer of 111, Inc. (NASDAQ: YI) a leading integrated online and offline healthcare platform, gave an address entitled "Driving Transformation inChina's Healthcare and Pharmaceutical Industry" at the 3...
2020-01-17 20:00
6535
China SXT Pharmaceuticals, Inc. Announced Regulatory Approval of Its DNA Exam Laboratory
TAIZHOU, China, Jan. 16, 2020 /PRNewswire/ -- China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) ("China SXT" or the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces ("TCMPs"), including Ad...
2020-01-16 21:00
5135
WuXi Biologics and Bayer Enter into an Acquisition Agreement on a Drug Product Plant in Germany
* First drug product facility in Europe to complement WuXi Biologics' existing commercial manufacturing capacities * WuXi Biologics will be the back-up manufacturer for Kovaltry™ of Bayer SHANGHAI and LEVERKUSEN, Germany, Jan. 15, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a ...
2020-01-16 10:39
9568
Hanmi Pharmaceutical participated in the 38th J.P. Morgan Healthcare Conference, announces that it is "ready to lead global pharmaceutical market with innovative R&D pipeline"
SEOUL, South Korea, Jan. 15, 2020 /PRNewswire/ -- The company, led by President and CEO Se-chang Kwon and co-representative Jong-soo Woo, participated in the 38th J.P. Morgan Healthcare Conference inSan Francisco during Jan. 13-15, which it presented its vision and major R&D strategies for 2020. ...
2020-01-16 07:30
354
WuXi Advanced Therapies Launches New World-Class AAV Vector Suspension Platform
PHILADELPHIA, Jan. 13, 2020 /PRNewswire/ -- WuXi Advanced Therapies, a leading global Contract Development and Manufacturing Organization (CDMO) offering end-to-end contract services for the advance therapies industry, announced today the expansion of its service capabilities by offering a fully ...
2020-01-13 22:00
5177
Say NO to Food Allergies, Taiwan User-Friendly Sensor & Tech (TFT) Creates Personalized Food Allergen Detection System
LAS VEGAS, Jan. 10, 2020 /PRNewswire/ -- Taiwan User-Friendly Sensor and Tech
(TFT) and other notable homegrown startups led by Taiwan Tech Arena (TTA) are
now showcasing their innovative solutions at CES 2020.
2020-01-11 00:00
832
GCAM Adds New Plasma Collection Center
FULLERTON, Calif. and YONGIN, South Korea, Jan. 10, 2020 /PRNewswire/ -- GCAM, Inc., a U.S. based plasma collection company, announced that it has added additional plasma collection centers; located inEdinburg, Texas. With the newest additions, GCAM now runs 12 plasma donation centers nationwide....
2020-01-10 22:00
750
VolitionRx Completes Acquisition of Octamer GmbH
AUSTIN, Texas, Jan. 10, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced the closing of the acquisition of the epigenetic reagent company Octamer GmbH ("Octamer") by its subsidiary Belgian Volition SPRL for approximately$725,000, consisting of cash and sh...
2020-01-10 21:00
13236
WuXi Biologics and Almirall Sign Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology Diseases
* The 12th global licensing partnership for WuXiBody™ since its launch in August 2018 showcasing the power and versatile applications of WuXiBody™ in multiple therapeutic areas SHANGHAI and BARCELONA, Spain, Jan. 9, 2020 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global o...
2020-01-09 17:10
1123
Transcenta Holding Secures $100 Million Series B Plus Financing
HONG KONG and SUZHOU and HANGZHOU, China, Jan. 8, 2020 /PRNewswire/ -- Transcenta Holding Limited ("Transcenta"), a global biotherapeutics company with fully-integrated capabilities in discovery, R&D, and manufacturing of antibody-based therapeutics, announces today that it has sealed a 100 millio...
2020-01-08 21:00
383
Gracell Initiates Investigational Study of the Technological Breakthrough TruUCAR™ Therapy for Relapsed or Refractory T-cell Malignancies
SUZHOU, China and SHANGHAI, Jan. 7, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell therapy company, today announced the initiation of an investigational study of GC027, the first product candidate developed usingTruUCAR™ to treat relapsed or refr...
2020-01-07 22:00
272
Beta Lifescience Announces the Online Availability of Quality Immune Checkpoint Proteins for Scientific Discoveries
FIREFILED, N.J., Jan. 7, 2020 /PRNewswire/ -- Beta Lifescience, a world leading biotech company based in NJ, USA, announces that scientists in the field of cancer immunotherapy, immune checkpoint, targeted therapy, etc. now have access to the quality immune checkpoint protein products through the...
2020-01-07 21:10
260
Presagen and Life Whisperer Announce Call-out for a Global IVF Clinic Collaboration at CES 2020
SAN MATEO, Calif. and ADELAIDE, Australia, Jan. 6, 2020 /PRNewswire/ -- Life Whisperer, the fertility arm of AI healthcare company Presagen, which operates out ofSan Mateo and South Australia, recently presented the results of groundbreaking research at the prestigious American Society for Reprod...
2020-01-06 23:47
273
Lianluo Smart Announces Receipt of Nasdaq Non-compliance of Stockholders' Equity Notification
BEIJING, Jan. 6, 2020 /PRNewswire/ -- Lianluo Smart Limited (the "Company") announced today that it has received a letter from the staff (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") onJanuary 2, 2020, providing notification that the Company no longer complies with the minimum of$2.5 mi...
2020-01-06 19:00
8258
CARsgen Appoints Yong Fan as Senior Vice President of Global Regulatory Affairs
SHANGHAI, Jan 6, 2020 /PRNewswire/ -- CARsgen Therapeutics, a clinical-stage company committed to developing Chimeric Antigen Receptor T cell therapies for cancer, today announced appointment ofYong Fan, MD, as Senior Vice President, Global Regulatory Affairs. Dr. Fan, will be responsible for CAR...
2020-01-06 18:00
322
Week's Top Stories
Most Reposted
Leading payments provider NIUM brings on Yogesh Sangle to drive payments ecosystem growth
[Picked up by 105 media titles]
2020-01-21 11:00
V1 Group Issues 75,000,000 Placing Shares at a Price of HK$0.2 Per Placing Share
[Picked up by 104 media titles]
2020-01-21 14:40Cognate BioServices closes Series B and completes acquisition of Cobra Biologics
[Picked up by 104 media titles]
2020-01-22 08:04
MassMutual Ventures announces USD $100 million second fund for Southeast Asia
[Picked up by 98 media titles]
2020-01-21 08:00Spot Welding Inspection Robots Spark a Revolution in the Automotive Industry
[Picked up by 96 media titles]
2020-01-22 10:00
Most Read
Spot Welding Inspection Robots Spark a Revolution in the Automotive Industry
2020-01-22 10:00
6290
ZTE and MTN launch the first 5G SA network in East Africa
2020-01-21 11:22
5673
V1 Group Issues 75,000,000 Placing Shares at a Price of HK$0.2 Per Placing Share
2020-01-21 14:40
5592